Risk factors affect the survival outcome of hard palatal and maxillary alveolus squamous cell carcinoma: 10-year review in a tertiary referral center

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Jul;110(1):11-7. doi: 10.1016/j.tripleo.2009.11.035. Epub 2010 Mar 17.

Abstract

Objective: Hard palatal cancer is relatively rare in the head and neck region. Treatment outcome, risk factors that lead to poor survival outcome, and treatment strategy are still controversial.

Study design: Retrospective study in a tertiary medical center.

Results: Surgery is a better treatment strategy than concurrent chemoradiation therapy (CCRT) for achieving positive survival outcomes. We also found a higher surgical salvage rate in patients with hard palatal cancer who had local recurrence or neck relapse. Soft palate or infratemporal fossa involvement had poor outcomes. Ulcerative tumor features, tumor volumes larger than 10 mL, and local recurrent tumors that could not undergo salvage surgery also had poorer survival outcomes in our study.

Conclusion: Surgical management is still the first choice for patients with hard palate or alveolus squamous cell carcinomas even when patients had local or neck regional recurrence.

Publication types

  • Comparative Study

MeSH terms

  • Alveolar Process / pathology
  • Alveolar Process / surgery*
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / surgery*
  • Chemotherapy, Adjuvant
  • Cisplatin / therapeutic use
  • Disease-Free Survival
  • Follow-Up Studies
  • Humans
  • Maxillary Neoplasms / pathology
  • Maxillary Neoplasms / surgery*
  • Middle Aged
  • Neck Dissection
  • Neoadjuvant Therapy
  • Neoplasm Invasiveness
  • Neoplasm Recurrence, Local / surgery
  • Neoplasm Staging
  • Palatal Neoplasms / pathology
  • Palatal Neoplasms / surgery*
  • Palate, Hard / pathology
  • Palate, Hard / surgery*
  • Palate, Soft / pathology
  • Radiotherapy Dosage
  • Radiotherapy, Adjuvant
  • Reoperation
  • Retrospective Studies
  • Risk Factors
  • Salvage Therapy
  • Survival Rate
  • Temporal Bone / pathology
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Cisplatin